Abstract:Telomere length (TL) and DNA methylation are associated with age and smoking exposure, as well as aging-related outcomes including lung cancer and mortality. A DNA methylation-based TL score (DNAmTL) was developed to estimate TL using DNA methylation array data, both in blood. DNAmTL effectively estimates telomere-related aging using 140 CpGs that are moderately enriched in sub-telomeric regions and not included in existing epigenetic clocks. We examined DNAmTL in individuals with a heavy smoking history (mean 56 pack years, range 11-185) in a nested lung cancer case-control study of 350 cases and 350 controls from the β-Carotene and Retinol Efficacy Trial identified through 2005. Twenty-two controls became cases with additional follow-up through 2013, so 328 controls and 372 cases were considered for these analyses. Leukocyte TL was measured using quantitative polymerase chain reaction (T/S ratio, log2-transformed), and DNA methylation was assayed on the Illumina EPIC array, in blood samples obtained on average 4.9 years prior to diagnosis in cases. We observed weak positive Pearson correlations between DNAmTL and TL in cases (r=0.19, p=0.0003) and controls (r=0.14, p=0.009) that persisted after age-adjustment: r=0.16, p=0.002 and r=0.14, p=0.014, respectively. Age-adjusted DNAmTL, but not TL, was longer for female compared to male cases (T=3.6, p=0.0004) and controls (T=2.2, p=0.03), and for those in the placebo compared to the intervention arm in cases (T=2.1, p=0.03) and controls (T=2.3, p=0.02). Linear regression models of TL and DNAmTL adjusted for age, sex, and race and ethnicity were not statistically significant for smoking variables at blood draw (pack years, current vs former smoking status, cigarettes smoked per day during smoking history, years smoked, years since quit), nor asbestos exposure in either cases or controls. Longer age-adjusted DNAmTL was associated with a lower hazard ratio (HR) for time to lung cancer death (0.60, 95% Confidence Interval (CI): 0.37-0.97) among cases (n=313 lung cancer-specific mortality events) in Cox proportional hazards models adjusted for age, sex, race and ethnicity, and time from blood draw to diagnosis with stage as a stratification variable (early I/II, advanced III/IV, unknown). Analogous age-adjusted TL model showed a similar direction but did not reach statistical significance (HR 0.86, CI: 0.71-1.05). Further adjustment of these models by DNA methylation-estimated leukocyte proportions of granulocytes, monocytes, natural killer, CD8+T, and CD4+T (excluding B cells) yielded similar results for age-adjusted DNAmTL (HR 0.54, CI: 0.31-0.92) and age-adjusted TL (HR 0.87, CI: 0.71-1.05). Our results illustrate that while DNAmTL may not be closely associated with smoking exposure among heavily exposed individuals, shorter DNAmTL may be more strongly associated with lung cancer mortality than TL in individuals with a heavy smoking history. Citation Format: Laurie Grieshober, Stefan Graw, Matt J. Barnett, Gary E. Goodman, Chu Chen, Devin C. Koestler, Carmen J. Marsit, Jennifer A. Doherty. Assessing a DNA methylation-based telomere length estimator in individuals with a heavy smoking history [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 3424.

Blood DNA Methylation Prospectively Predicts Mortality in Former and Current Smokers in the COPDGene Study

Blood DNA Methylation Sites Predict Death Risk in a Longitudinal Study of 12, 300 Individuals

Integrative analysis of clinical and epigenetic biomarkers of mortality

DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD

Epigenetic prediction of complex traits and death

The impact of genetic variation and cigarette smoke on DNA methylation in current and former smokers from the COPDGene study

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

DNA methylation age of blood predicts all-cause mortality in later life

The Blood DNA Methylation Clock GrimAge Is a Robust Surrogate for Airway Epithelia Aging

Epigenome-wide association study of whole blood gene expression in Framingham Heart Study participants provides molecular insight into the potential role of CHRNA5 in cigarette smoking-related lung diseases

Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease

Abstract 3424: Assessing a DNA methylation-based telomere length estimator in individuals with a heavy smoking history

Variable DNA methylation of aging-related genes is associated with male COPD.

SIPA1L3 Methylation Modifies the Benefit of Smoking Cessation on Lung Adenocarcinoma Survival: an Epigenomic–smoking Interaction Analysis

Investigating the DNA methylation profile of e-cigarette use

A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer

Smoking-Related DNA Methylation is Associated with DNA Methylation Phenotypic Age Acceleration: the Veterans Affairs Normative Aging Study

Epigenome-wide Analysis of DNA Methylation in Lung Tissue Shows Concordance with Blood Studies and Identifies Tobacco Smoke-Inducible Enhancers

DNA Methylation Changes of Whole Blood Cells in Response to Active Smoking Exposure in Adults: a Systematic Review of DNA Methylation Studies.

Using Cg05575921 methylation to predict lung cancer risk: a potentially bias-free precision epigenetics approach

Comparative Validation of an Epigenetic Mortality Risk Score with Three Aging Biomarkers for Predicting Mortality Risks among Older Adult Males